BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Domínguez-Muñoz JE. Pancreatic exocrine insufficiency: diagnosis and treatment. J Gastroenterol Hepatol 2011;26 Suppl 2:12-6. [PMID: 21323992 DOI: 10.1111/j.1440-1746.2010.06600.x] [Cited by in Crossref: 102] [Cited by in F6Publishing: 89] [Article Influence: 9.3] [Reference Citation Analysis]
Number Citing Articles
1 Percy K, Ooi Y, Nahm C, Simpson F, Hickey G, Sahni S, Chesher D, Itchins M, Pavlakis N, Tsang V, Clifton-bligh R, Gill A, Samra J, Mittal A. Defining the rate of nutritional and metabolic derangements after pancreatic resection. Pancreatology 2022. [DOI: 10.1016/j.pan.2022.07.014] [Reference Citation Analysis]
2 Moore HN, Chirco AR, Plescia T, Ahmed S, Jachniewicz B, Rajasekar G, Ali MR, Lyo V. Exocrine pancreatic insufficiency after bariatric surgery: a bariatric surgery center of excellence experience. Surg Endosc 2022. [PMID: 35768735 DOI: 10.1007/s00464-022-09388-3] [Reference Citation Analysis]
3 Shetty R, Kumbhar G, Thomas A, Pearlin B, Chowdhury SD, Chandramohan A. How Are Imaging Findings Associated with Exocrine Insufficiency in Idiopathic Chronic Pancreatitis? Indian J Radiol Imaging. [DOI: 10.1055/s-0042-1744138] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Kunovský L, Dítě P, Jabandžiev P, Eid M, Poredská K, Vaculová J, Sochorová D, Janeček P, Tesaříková P, Blaho M, Trna J, Hlavsa J, Kala Z. Causes of Exocrine Pancreatic Insufficiency Other Than Chronic Pancreatitis. J Clin Med 2021;10:5779. [PMID: 34945075 DOI: 10.3390/jcm10245779] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
5 Wen H, Li Q, Lu N, Su YY, Ma PH, Zhang MX. Intestinal flora and pancreatitis: Present and future. Shijie Huaren Xiaohua Zazhi 2021; 29(22): 1269-1275 [DOI: 10.11569/wcjd.v29.i22.1269] [Reference Citation Analysis]
6 Shiba S, Miyasaka Y, Okamoto M, Komatsu S, Okazaki S, Shibuya K, Ohno T. Deterioration of pancreatic exocrine function in carbon ion radiotherapy for pancreatic cancer. Clin Transl Radiat Oncol 2021;31:80-5. [PMID: 34746451 DOI: 10.1016/j.ctro.2021.09.007] [Reference Citation Analysis]
7 Shandro BM, Chen J, Ritehnia J, Poullis A. Associations with pancreatic exocrine insufficiency: An United Kingdom single-centre study. World J Clin Cases 2021; 9(31): 9469-9480 [PMID: 34877281 DOI: 10.12998/wjcc.v9.i31.9469] [Reference Citation Analysis]
8 Uribarri-Gonzalez L, Nieto-García L, Martis-Sueiro A, Dominguez-Muñoz JE. Exocrine pancreatic function and dynamic of digestion after restrictive and malabsorptive bariatric surgery: a prospective, cross-sectional, and comparative study. Surg Obes Relat Dis 2021:S1550-7289(21)00316-6. [PMID: 34332909 DOI: 10.1016/j.soard.2021.06.019] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
9 Trapnell BC, Chen S, Khurmi R, Bodhani A, Kapoor M, Haupt M. Hospitalization rates among patients with cystic fibrosis using pancreatic enzyme replacement therapy. Chron Respir Dis 2020;17:1479973119900612. [PMID: 31984768 DOI: 10.1177/1479973119900612] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
10 Bourne DM, White H, French JJ, Leeds JS. A retrospective cohort study of nutritional status, nutritional interventions and hospital admissions in patients with chronic pancreatitis managed at a tertiary referral centre. Clin Nutr ESPEN 2021;43:290-5. [PMID: 34024529 DOI: 10.1016/j.clnesp.2021.03.038] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Sridhar RP, Yacob M, Chowdhury SD, Balasubramanian KA, Samarasam I. Exocrine Pancreatic Insufficiency Following Gastric Resectional Surgery-is Routine Pancreatic Enzyme Replacement Therapy Necessary? Indian J Surg Oncol 2021;12:391-6. [PMID: 34295084 DOI: 10.1007/s13193-021-01315-7] [Reference Citation Analysis]
12 Dominguez-Muñoz JE. Breath testing for the diagnosis of pancreatic disease. Curr Opin Gastroenterol 2020;36:421-7. [PMID: 32740002 DOI: 10.1097/MOG.0000000000000664] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
13 Dominguez-Muñoz JE. Management of pancreatic exocrine insufficiency.Curr Opin Gastroenterol. 2019;35:455-459. [PMID: 31219829 DOI: 10.1097/MOG.0000000000000562] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
14 Hart PA, Conwell DL. Chronic Pancreatitis: Managing a Difficult Disease. Am J Gastroenterol 2020;115:49-55. [PMID: 31764092 DOI: 10.14309/ajg.0000000000000421] [Cited by in Crossref: 13] [Cited by in F6Publishing: 23] [Article Influence: 6.5] [Reference Citation Analysis]
15 Søfteland E, Poulsen JL, Starup-linde J, Christensen TT, Olesen SS, Singh S, Vestergaard P, Drewes AM, Dimcevski G. Pancreatic exocrine insufficiency in diabetes mellitus - prevalence and characteristics. European Journal of Internal Medicine 2019;68:18-22. [DOI: 10.1016/j.ejim.2019.07.021] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
16 Sankararaman S, Schindler T, Sferra TJ. Management of Exocrine Pancreatic Insufficiency in Children. Nutrition in Clinical Practice 2019;34:S27-42. [DOI: 10.1002/ncp.10388] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
17 Storck LJ, Imoberdorf R, Ballmer PE. Nutrition in Gastrointestinal Disease: Liver, Pancreatic, and Inflammatory Bowel Disease. J Clin Med 2019;8:E1098. [PMID: 31349549 DOI: 10.3390/jcm8081098] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
18 Mitchell T, Clarke L, Goldberg A, Bishop KS. Pancreatic Cancer Cachexia: The Role of Nutritional Interventions. Healthcare (Basel) 2019;7:E89. [PMID: 31323984 DOI: 10.3390/healthcare7030089] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
19 Thogari K, Tewari M, Shukla SK, Mishra SP, Shukla HS. Assessment of Exocrine Function of Pancreas Following Pancreaticoduodenectomy. Indian J Surg Oncol 2019;10:258-67. [PMID: 31168245 DOI: 10.1007/s13193-019-00901-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
20 Ito K, Matsuura K, Mihara Y, Sakamoto Y, Hasegawa K, Kokudo N, Shimizu T. Delivery of pancreatic digestive enzymes into the gastrointestinal tract by pancreatic exocrine tissue transplant.Sci Rep. 2019;9:5922. [PMID: 30976035 DOI: 10.1038/s41598-019-42362-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
21 Khatkov IE, Maev IV, Abdulkhakov SR, Alekseenko SA, Alikhanov RB, Bakulin IG, Bakulina NV, Baranovskiy AY, Beloborodova EV, Belousova EA, Voskanyan SE, Vinokurova LV, Grinevich VB, Darvin VV, Dubtsova EA, Dyuzheva TG, Egorov VI, Efanov MG, Izrailov RE, Korobka VL, Kotiv BN, Kokhanenko NY, Kucheryavyy YA, Livzan MA, Lyadov VK, Nikolskaya KA, Osipenko MF, Pasechnikov VD, Plotnikova EY, Sablin OA, Simanenkov VI, Tsvirkun VV, Tsukanov VV, Shabunin AV, Bordin DS. Russian consensus on exo- and endocrine pancreatic insufficiency after surgical treatment. Ter Arkh 2018;90:13-26. [PMID: 30701935 DOI: 10.26442/terarkh201890813-26] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
22 Dominguez-Muñoz JE. Diagnosis and treatment of pancreatic exocrine insufficiency. Curr Opin Gastroenterol 2018;34:349-54. [PMID: 29889111 DOI: 10.1097/MOG.0000000000000459] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 10.3] [Reference Citation Analysis]
23 Landers A, Brown H, Strother M. The effectiveness of pancreatic enzyme replacement therapy for malabsorption in advanced pancreatic cancer, a pilot study. Palliat Care 2019;12:1178224218825270. [PMID: 30799929 DOI: 10.1177/1178224218825270] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
24 Hendifar AE, Petzel MQB, Zimmers TA, Denlinger CS, Matrisian LM, Picozzi VJ, Rahib L; Precision Promise Consortium. Pancreas Cancer-Associated Weight Loss. Oncologist 2019;24:691-701. [PMID: 30591550 DOI: 10.1634/theoncologist.2018-0266] [Cited by in Crossref: 42] [Cited by in F6Publishing: 55] [Article Influence: 10.5] [Reference Citation Analysis]
25 Johnson CD, Williamson N, Janssen-van Solingen G, Arbuckle R, Johnson C, Simpson S, Staab D, Dominguez-Munoz E, Levy P, Connett G, Lerch MM. Psychometric evaluation of a patient-reported outcome measure in pancreatic exocrine insufficiency (PEI). Pancreatology 2019;19:182-90. [PMID: 30528109 DOI: 10.1016/j.pan.2018.11.013] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 4.5] [Reference Citation Analysis]
26 de la Iglesia D, Vallejo-senra N, López-lópez A, Iglesias-garcia J, Lariño-noia J, Nieto-garcía L, Domínguez-muñoz JE. Pancreatic exocrine insufficiency and cardiovascular risk in patients with chronic pancreatitis: A prospective, longitudinal cohort study: Cardiovascular risk in pancreatitis. Journal of Gastroenterology and Hepatology 2019;34:277-83. [DOI: 10.1111/jgh.14460] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
27 Zsóri G, Illés D, Terzin V, Ivány E, Czakó L. Exocrine pancreatic insufficiency in type 1 and type 2 diabetes mellitus: do we need to treat it? A systematic review. Pancreatology 2018;18:559-65. [PMID: 29779830 DOI: 10.1016/j.pan.2018.05.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
28 Pham A, Forsmark C. Chronic pancreatitis: review and update of etiology, risk factors, and management. F1000Res. 2018;7. [PMID: 29946424 DOI: 10.12688/f1000research.12852.1] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 9.8] [Reference Citation Analysis]
29 Dunleavy L, Al-Mukhtar A, Halliday V. Pancreatic enzyme replacement therapy following surgery for pancreatic cancer: An exploration of patient self-management. Clin Nutr ESPEN 2018;26:97-103. [PMID: 29908691 DOI: 10.1016/j.clnesp.2018.04.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
30 Domínguez-muñoz JE, Phillips M. Nutritional Therapy in Chronic Pancreatitis. Gastroenterology Clinics of North America 2018;47:95-106. [DOI: 10.1016/j.gtc.2017.09.004] [Cited by in Crossref: 32] [Cited by in F6Publishing: 24] [Article Influence: 8.0] [Reference Citation Analysis]
31 Ní Chonchubhair HM, Bashir Y, Dobson M, Ryan BM, Duggan SN, Conlon KC. The prevalence of small intestinal bacterial overgrowth in non-surgical patients with chronic pancreatitis and pancreatic exocrine insufficiency (PEI). Pancreatology 2018;18:379-85. [PMID: 29502987 DOI: 10.1016/j.pan.2018.02.010] [Cited by in Crossref: 21] [Cited by in F6Publishing: 26] [Article Influence: 5.3] [Reference Citation Analysis]
32 Othman MO, Harb D, Barkin JA. Introduction and practical approach to exocrine pancreatic insufficiency for the practicing clinician. Int J Clin Pract. 2018;72. [PMID: 29405509 DOI: 10.1111/ijcp.13066] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
33 Singh VK, Haupt ME, Geller DE, Hall JA, Quintana Diez PM. Less common etiologies of exocrine pancreatic insufficiency. World J Gastroenterol 2017; 23(39): 7059-7076 [PMID: 29093615 DOI: 10.3748/wjg.v23.i39.7059] [Cited by in CrossRef: 61] [Cited by in F6Publishing: 45] [Article Influence: 12.2] [Reference Citation Analysis]
34 Marra-Lopez Valenciano C, Bolado Concejo F, Marín Serrano E, Millastre Bocos J, Martínez-Moneo E, Pérez Rodríguez E, Francisco González M, Del Pozo-García A, Hernández Martín A, Labrador Barba E, Orera Peña ML, de-Madaria E. Prevalence of exocrine pancreatic insufficiency in patients with chronic pancreatitis without follow-up. PANCR-EVOL Study. Gastroenterol Hepatol 2018;41:77-86. [PMID: 28935122 DOI: 10.1016/j.gastrohep.2017.08.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
35 Yilmaz A, Hagberg L. Exocrine pancreatic insufficiency is common in people living with HIV on effective antiretroviral therapy. Infect Dis (Lond) 2018;50:193-9. [PMID: 28838283 DOI: 10.1080/23744235.2017.1370126] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
36 Segelov E, Lordick F, Goldstein D, Chantrill LA, Croagh D, Lawrence B, Arnold D, Chau I, Obermannova R, Price TJ. Current challenges in optimizing systemic therapy for patients with pancreatic cancer: expert perspectives from the Australasian Gastrointestinal Trials Group (AGITG) with invited international faculty. Expert Rev Anticancer Ther 2017;17:951-64. [PMID: 28817982 DOI: 10.1080/14737140.2017.1369882] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
37 Petzel MQB, Hoffman L. Nutrition Implications for Long-Term Survivors of Pancreatic Cancer Surgery. Nutr Clin Pract 2017;32:588-98. [DOI: 10.1177/0884533617722929] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
38 Gupta R, Amanam I, Chung V. Current and future therapies for advanced pancreatic cancer. J Surg Oncol 2017;116:25-34. [PMID: 28591939 DOI: 10.1002/jso.24623] [Cited by in Crossref: 41] [Cited by in F6Publishing: 76] [Article Influence: 8.2] [Reference Citation Analysis]
39 Domínguez-Muñoz JE, D Hardt P, Lerch MM, Löhr MJ. Potential for Screening for Pancreatic Exocrine Insufficiency Using the Fecal Elastase-1 Test. Dig Dis Sci 2017;62:1119-30. [PMID: 28315028 DOI: 10.1007/s10620-017-4524-z] [Cited by in Crossref: 57] [Cited by in F6Publishing: 41] [Article Influence: 11.4] [Reference Citation Analysis]
40 Ramsey ML, Conwell DL, Hart PA. Complications of Chronic Pancreatitis. Dig Dis Sci. 2017;62:1745-1750. [PMID: 28281169 DOI: 10.1007/s10620-017-4518-x] [Cited by in Crossref: 59] [Cited by in F6Publishing: 48] [Article Influence: 11.8] [Reference Citation Analysis]
41 Saito T, Hirano K, Isayama H, Nakai Y, Saito K, Umefune G, Akiyama D, Watanabe T, Takagi K, Hamada T, Takahara N, Uchino R, Mizuno S, Kogure H, Matsubara S, Yamamoto N, Tada M, Koike K. The Role of Pancreatic Enzyme Replacement Therapy in Unresectable Pancreatic Cancer: A Prospective Cohort Study. Pancreas 2017;46:341-6. [DOI: 10.1097/mpa.0000000000000767] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 4.2] [Reference Citation Analysis]
42 Madzak A, Engjom T, Wathle GK, Olesen SS, Tjora E, Njølstad PR, Lærum BN, Drewes AM, Dimcevski G, Frøkjær JB, Haldorsen IS. Secretin-stimulated MRI assessment of exocrine pancreatic function in patients with cystic fibrosis and healthy controls. Abdom Radiol (NY) 2017;42:890-9. [PMID: 27832324 DOI: 10.1007/s00261-016-0972-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
43 Sheth SG, Conwell DL, Whitcomb DC, Alsante M, Anderson MA, Barkin J, Brand R, Cote GA, Freedman SD, Gelrud A, Gorelick F, Lee LS, Morgan K, Pandol S, Singh VK, Yadav D, Wilcox CM, Hart PA. Academic Pancreas Centers of Excellence: Guidance from a multidisciplinary chronic pancreatitis working group at PancreasFest. Pancreatology. 2017;17:419-430. [PMID: 28268158 DOI: 10.1016/j.pan.2017.02.015] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
44 Hoadley A, Sandanayake N, Long G. Atrophic exocrine pancreatic insufficiency associated with anti-PD1 therapy. Annals of Oncology 2017;28:434-5. [DOI: 10.1093/annonc/mdw626] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
45 Erchinger F, Engjom T, Jurmy P, Tjora E, Gilja OH, Dimcevski G. Fecal Fat Analyses in Chronic Pancreatitis Importance of Fat Ingestion before Stool Collection. PLoS One. 2017;12:e0169993. [PMID: 28095460 DOI: 10.1371/journal.pone.0169993] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
46 Whitcomb DC, Bodhani A, Beckmann K, Sander-Struckmeier S, Liu S, Fuldeore M, Pollack PF, Khurmi RP. Efficacy and Safety of Pancrelipase/Pancreatin in Patients With Exocrine Pancreatic Insufficiency and a Medical History of Diabetes Mellitus. Pancreas 2016;45:679-86. [PMID: 26495784 DOI: 10.1097/MPA.0000000000000514] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
47 Zhang Z, Chen F, Zhang R, Deng Z, McClements DJ. Encapsulation of Pancreatic Lipase in Hydrogel Beads with Self-Regulating Internal pH Microenvironments: Retention of Lipase Activity after Exposure to Gastric Conditions. J Agric Food Chem 2016;64:9616-23. [PMID: 27966930 DOI: 10.1021/acs.jafc.6b04644] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 4.5] [Reference Citation Analysis]
48 Chowdhury SD, Kurien RT, Ramachandran A, Joseph AJ, Simon EG, Dutta AK, David D, Kumar C B, Samuel P, Balasubramaniam KA. Pancreatic exocrine insufficiency: Comparing fecal elastase 1 with 72-h stool for fecal fat estimation. Indian J Gastroenterol. 2016;35:441-444. [PMID: 27878466 DOI: 10.1007/s12664-016-0714-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
49 Martin-Richard M, Ginès A, Ayuso JR, Sabater L, Fabregat J, Mendez R, Fernández-Esparrach G, Molero X, Vaquero EC, Cuatrecasas M, Ferrández A, Maurel J; Comité multidisciplinar para la actualización de las recomendaciones para el manejo de las lesiones pre-malignas y el adenocarcinoma de páncreas. [Recommendations for the diagnosis, staging and treatment of pre-malignant lesions and pancreatic adenocarcinoma]. Med Clin (Barc) 2016;147:465.e1-8. [PMID: 27726847 DOI: 10.1016/j.medcli.2016.07.033] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
50 Sant KE, Jacobs HM, Xu J, Borofski KA, Moss LG, Moss JB, Timme-Laragy AR. Assessment of Toxicological Perturbations and Variants of Pancreatic Islet Development in the Zebrafish Model. Toxics 2016;4:20. [PMID: 28393070 DOI: 10.3390/toxics4030020] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
51 Hobbs PM, Johnson WG, Graham DY. Management of pain in chronic pancreatitis with emphasis on exogenous pancreatic enzymes. World J Gastrointest Pharmacol Ther 2016; 7(3): 370-386 [PMID: 27602238 DOI: 10.4292/wjgpt.v7.i3.370] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
52 Chaari A, Abdel Hakim K, Bousselmi K, Etman M, El Bahr M, El Saka A, Hamza E, Ismail M, Khalil EM, Kauts V, Casey WF. Pancreatic injury in patients with septic shock: A literature review. World J Gastrointest Oncol 2016; 8(7): 526-531 [PMID: 27559431 DOI: 10.4251/wjgo.v8.i7.526] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
53 Rathmann W, Haastert B, Oscarsson J, Berglind N, Lindkvist B, Wareham NJ. Association of faecal elastase 1 with non-fasting triglycerides in type 2 diabetes. Pancreatology 2016;16:563-9. [PMID: 27086060 DOI: 10.1016/j.pan.2016.03.015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
54 Chung WS, Lin CL. Comorbid risks of deep vein thrombosis and pulmonary thromboembolism in patients with chronic pancreatitis: a nationwide cohort study. J Thromb Haemost 2016;14:98-104. [PMID: 26563680 DOI: 10.1111/jth.13195] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
55 Philpott H, Nandurkar S, Lubel J, Gibson PR. Food, fibre, bile acids and the pelvic floor: An integrated low risk low cost approach to managing irritable bowel syndrome. World J Gastroenterol 2015; 21(40): 11379-11386 [PMID: 26525925 DOI: 10.3748/wjg.v21.i40.11379] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
56 Hart PA, Conwell DL. Diagnosis of exocrine pancreatic insufficiency. Curr Treat Options Gastroenterol. 2015;13:347-353. [PMID: 26077487 DOI: 10.1007/s11938-015-0057-8] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
57 Lindkvist B, Phillips ME, Domínguez-Muñoz JE. Clinical, anthropometric and laboratory nutritional markers of pancreatic exocrine insufficiency: Prevalence and diagnostic use. Pancreatology 2015;15:589-97. [PMID: 26243045 DOI: 10.1016/j.pan.2015.07.001] [Cited by in Crossref: 63] [Cited by in F6Publishing: 56] [Article Influence: 9.0] [Reference Citation Analysis]
58 Taylor CJ, Chen K, Horvath K, Hughes D, Lowe ME, Mehta D, Orabi AI, Screws J, Thomson M, Van Biervliet S, Verkade HJ, Husain SZ, Wilschanski M. ESPGHAN and NASPGHAN Report on the Assessment of Exocrine Pancreatic Function and Pancreatitis in Children. Journal of Pediatric Gastroenterology & Nutrition 2015;61:144-53. [DOI: 10.1097/mpg.0000000000000830] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
59 Phillips ME. Pancreatic exocrine insufficiency following pancreatic resection. Pancreatology. 2015;15:449-455. [PMID: 26145836 DOI: 10.1016/j.pan.2015.06.003] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 6.0] [Reference Citation Analysis]
60 Mattar R, Lima GA, da Costa MZ, Silva-Etto JM, Guarita D, Carrilho FJ. Comparison of fecal elastase 1 for exocrine pancreatic insufficiency evaluation between ex-alcoholics and chronic pancreatitis patients. Arq Gastroenterol 2014;51:297-301. [PMID: 25591157 DOI: 10.1590/S0004-28032014000400006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
61 Szmola R, Farkas G, Hegyi P, Czakó L, Dubravcsik Z, Hritz I, Kelemen D, Lásztity N, Morvay Z, Oláh A, Párniczky A, Rubovszky G, Sahin-Tóth M, Szentkereszti Z, Szücs Á, Takács T, Tiszlavicz L, Pap Á; Magyar Hasnyálmirigy Munkacsoport, Hungarian Pancreatic Study Group. [Pancreatic cancer. Evidence based management guidelines of the Hungarian Pancreatic Study Group]. Orv Hetil 2015;156:326-39. [PMID: 25662149 DOI: 10.1556/OH.2015.30063] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
62 Cummings MH, Chong L, Hunter V, Kar PS, Meeking DR, Cranston IC. Gastrointestinal symptoms and pancreatic exocrine insufficiency in type 1 and type 2 diabetes. Pract Diab 2015;32:54-8. [DOI: 10.1002/pdi.1924] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
63 Muniraj T, Aslanian HR, Farrell J, Jamidar PA. Chronic pancreatitis, a comprehensive review and update. Part I: epidemiology, etiology, risk factors, genetics, pathophysiology, and clinical features. Dis Mon 2014;60:530-50. [PMID: 25510320 DOI: 10.1016/j.disamonth.2014.11.002] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 7.0] [Reference Citation Analysis]
64 Broide E, Shirin H. Evaluation of Exalenz Bioscience's BreathID for Helicobacter pylori detection. Expert Rev Mol Diagn 2015;15:299-312. [PMID: 25634297 DOI: 10.1586/14737159.2015.982537] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
65 Landers A, Muircroft W, Brown H. Pancreatic enzyme replacement therapy (PERT) for malabsorption in patients with metastatic pancreatic cancer. BMJ Support Palliat Care. 2016;6:75-79. [PMID: 25164613 DOI: 10.1136/bmjspcare-2014-000694] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
66 Dominguez-Muñoz JE, Iglesias-Garcia J, Castiñeira Alvariño M, Luaces Regueira M, Lariño-Noia J. EUS elastography to predict pancreatic exocrine insufficiency in patients with chronic pancreatitis. Gastrointest Endosc 2015;81:136-42. [PMID: 25088920 DOI: 10.1016/j.gie.2014.06.040] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 4.3] [Reference Citation Analysis]
67 Li L, Somerset S. The clinical significance of the gut microbiota in cystic fibrosis and the potential for dietary therapies. Clin Nutr 2014;33:571-80. [PMID: 24767984 DOI: 10.1016/j.clnu.2014.04.004] [Cited by in Crossref: 44] [Cited by in F6Publishing: 36] [Article Influence: 5.5] [Reference Citation Analysis]
68 Afghani E, Sinha A, Singh VK. An overview of the diagnosis and management of nutrition in chronic pancreatitis. Nutr Clin Pract 2014;29:295-311. [PMID: 24743046 DOI: 10.1177/0884533614529996] [Cited by in Crossref: 33] [Cited by in F6Publishing: 23] [Article Influence: 4.1] [Reference Citation Analysis]
69 Benavides M, Abad A, Ales I, Carrato A, Díaz Rubio E, Gallego J, García-foncillas J, Grávalos C, Laquente B, Pericay C, Rivera F, Tabernero J, Aranda E. TTD consensus document on the diagnosis and management of exocrine pancreatic cancer. Clin Transl Oncol 2014;16:865-78. [DOI: 10.1007/s12094-014-1177-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
70 Stockley AJ. Case report of exocrine pancreatic insufficiency in two palliative care patients. Palliat Med 2014;28:992-4. [PMID: 24699789 DOI: 10.1177/0269216314528401] [Reference Citation Analysis]
71 Di Gangi IM, Vrhovsek U, Pazienza V, Mattivi F. Analytical metabolomics-based approaches to pancreatic cancer. TrAC Trends in Analytical Chemistry 2014;55:94-116. [DOI: 10.1016/j.trac.2013.12.006] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
72 Sander-Struckmeier S, Beckmann K, Janssen-van Solingen G, Pollack P. Retrospective analysis to investigate the effect of concomitant use of gastric acid-suppressing drugs on the efficacy and safety of pancrelipase/pancreatin (CREON®) in patients with pancreatic exocrine insufficiency. Pancreas. 2013;42:983-989. [PMID: 23587850 DOI: 10.1097/mpa.0b013e31828784ef] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
73 Lindkvist B. Diagnosis and treatment of pancreatic exocrine insufficiency. World J Gastroenterol 2013; 19(42): 7258-7266 [PMID: 24259956 DOI: 10.3748/wjg.v19.i42.7258] [Cited by in CrossRef: 116] [Cited by in F6Publishing: 86] [Article Influence: 12.9] [Reference Citation Analysis]
74 Olesen AE, Brokjaer A, Fisher IW, Larsen IM. Pharmacological challenges in chronic pancreatitis. World J Gastroenterol 2013; 19(42): 7302-7307 [PMID: 24259961 DOI: 10.3748/wjg.v19.i42.7302] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
75 Wang S, Ma L, Zhuang Y, Jiang B, Zhang X. Screening and risk factors of exocrine pancreatic insufficiency in critically ill adult patients receiving enteral nutrition. Crit Care. 2013;17:R171. [PMID: 23924602 DOI: 10.1186/cc12850] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
76 Braithwaite MC, Kumar P, Tyagi C, Tomar LK, Choonara YE, Pillay V. Vitamin D therapy and related metabolomics: is the calciferol dose and form the only requirements for successful clinical therapeutics? Med Hypotheses 2013;81:656-63. [PMID: 23920270 DOI: 10.1016/j.mehy.2013.07.022] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
77 Brelian D, Tenner S. Diarrhoea due to pancreatic diseases. Best Pract Res Clin Gastroenterol 2012;26:623-31. [PMID: 23384807 DOI: 10.1016/j.bpg.2012.11.010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
78 Xu SB, Zhu YP, Zhou W, Xie K, Mou YP. Patients get more long-term benefit from central pancreatectomy than distal resection: a meta-analysis. Eur J Surg Oncol 2013;39:567-74. [PMID: 23465182 DOI: 10.1016/j.ejso.2013.02.003] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
79 Sandhu DK, Surawicz C. Update on chronic diarrhea: a run-through for the clinician. Curr Gastroenterol Rep 2012;14:421-7. [PMID: 22903799 DOI: 10.1007/s11894-012-0283-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
80 Gooden HM, White KJ. Pancreatic cancer and supportive care--pancreatic exocrine insufficiency negatively impacts on quality of life. Support Care Cancer. 2013;21:1835-1841. [PMID: 23397095 DOI: 10.1007/s00520-013-1729-3] [Cited by in Crossref: 58] [Cited by in F6Publishing: 59] [Article Influence: 6.4] [Reference Citation Analysis]
81 Ramesh H, Reddy N, Bhatia S, Rajkumar JS, Bapaye A, Kini D, Kalla M, Thorat V. A 51-week, open-label clinical trial in India to assess the efficacy and safety of pancreatin 40000 enteric-coated minimicrospheres in patients with pancreatic exocrine insufficiency due to chronic pancreatitis. Pancreatology. 2013;13:133-139. [PMID: 23561971 DOI: 10.1016/j.pan.2013.01.009] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 3.7] [Reference Citation Analysis]
82 Kluger N, Jokinen M, Krohn K, Ranki A. Gastrointestinal Manifestations in APECED Syndrome. Journal of Clinical Gastroenterology 2013;47:112-20. [DOI: 10.1097/mcg.0b013e31827356e1] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 3.8] [Reference Citation Analysis]
83 Yoshikawa K, Mitsunaga S, Kinoshita T, Konishi M, Takahashi S, Gotohda N, Kato Y, Aizawa M, Ochiai A. Impact of tumor-associated macrophages on invasive ductal carcinoma of the pancreas head. Cancer Sci 2012;103:2012-20. [PMID: 22931216 DOI: 10.1111/j.1349-7006.2012.02411.x] [Cited by in Crossref: 88] [Cited by in F6Publishing: 90] [Article Influence: 8.8] [Reference Citation Analysis]
84 Enrique Domínguez-muñoz J, Iglesias-garcía J. Últimos avances en pancreatitis crónica. Gastroenterología y Hepatología 2012;35:86-90. [DOI: 10.1016/s0210-5705(12)70039-0] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
85 Nakajima K, Oshida H, Muneyuki T, Kakei M. Pancrelipase: an evidence-based review of its use for treating pancreatic exocrine insufficiency. Core Evid. 2012;7:77-91. [PMID: 22936895 DOI: 10.2147/ce.s26705] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
86 Olesen AE, Olofsen E, Olesen SS, Staahl C, Andresen T, Dahan A, Drewes AM. The absorption profile of pregabalin in chronic pancreatitis. Basic Clin Pharmacol Toxicol. 2012;111:385-390. [PMID: 22716224 DOI: 10.1111/j.1742-7843.2012.00914.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
87 Mendes AA, Oliveira PC, de Castro HF. Properties and biotechnological applications of porcine pancreatic lipase. Journal of Molecular Catalysis B: Enzymatic 2012;78:119-34. [DOI: 10.1016/j.molcatb.2012.03.004] [Cited by in Crossref: 143] [Cited by in F6Publishing: 116] [Article Influence: 14.3] [Reference Citation Analysis]
88 Wiebe LA. A Myriad of Symptoms: New Approaches to Optimizing Palliative Care of Patients with Advanced Pancreatic Cancer. American Society of Clinical Oncology Educational Book 2012. [DOI: 10.14694/edbook_am.2012.32.15] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
89 Yoo K. Medical Treatment of Chronic Pancreatitis. Korean J Med 2012;83:18. [DOI: 10.3904/kjm.2012.83.1.18] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]